-+ 0.00%
-+ 0.00%
-+ 0.00%

NANOVIRICIDES, INC: RECEIVED REGULATORY APPROVAL FOR A PHASE II CLINICAL TRIAL OF NV-387 ORAL GUMMIES AS A TREATMENT FOR EBOLA IN DR CONGO

Reuters·08/10/2026 12:31:45

Please log in to view news